Browse > Article
http://dx.doi.org/10.4142/jvs.2007.8.1.21

Disposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves  

Rajput, Neetu (Department of Pharmacology and Toxicology, College of Veterinary Science, Guru Angad Dev Veterinary and Animal Sciences University)
Dumka, Vinod K. (Department of Pharmacology and Toxicology, College of Veterinary Science, Guru Angad Dev Veterinary and Animal Sciences University)
Sandhu, Harpal S. (Department of Pharmacology and Toxicology, College of Veterinary Science, Guru Angad Dev Veterinary and Animal Sciences University)
Publication Information
Journal of Veterinary Science / v.8, no.1, 2007 , pp. 21-25 More about this Journal
Abstract
We investigated the disposition kinetics and urinary excretion of cefpirome in buffalo calves after a single intravenous administration of 10 mg/kg. Also, an appropriate dosage regimen was calculated. At 1 min after injection, the concentration of cefpirome in the plasma was 57.4 ± 0.72 μg/ml, which declined to 0.22 ± 0.01 μg/ml at 24 h. The cefpirome was rapidly distributed from the blood to the tissue compartment as shown by the high distribution coefficient values (8.67 ± 0.46/h), and by the drug’s rate of transfer constant from the central to the peripheral compartment, K12 (4.94 ± 0.31/h). The elimination halflife and the volume of distribution were 2.14 ± 0.02 h and 0.42 ± 0.005 l/kg, respectively. Once the distribution equilibrium was reached between the tissues and plasma, the total body clearance (ClB) and the ratio of the drug present in the peripheral to the central compartment (T/P ratio) were 0.14 ± 0.002 l/kg/h and 1.73 ± 0.06, respectively. Based on the pharmacokinetic parameters we obtained, an appropriate intravenous cefpirome dosage regimen for treating cefpiromesensitive bacteria in buffalo calves would be 8.0 mg/kg repeated at 12 h intervals for 5 days, or until persistence of the bacterial infection occurred.
Keywords
buffalo; cefpirome; cephalosporins; dosage; pharmacokinetics;
Citations & Related Records

Times Cited By Web Of Science : 3  (Related Records In Web of Science)
Times Cited By SCOPUS : 3
연도 인용수 순위
1 Arret B, Johnson DP, Kirshbaum A. Outline of details for microbiological assays of antibiotics: second revision. J Pharm Sci 1971, 60, 1689-1694   DOI
2 Dardi MS, Sharma SK, Srivastava AK. Pharmacokinetics and dosage regimen of ceftriaxone in buffalo calves. Vet Res Commun 2004, 28, 331-338
3 Hancock RE, Bellido F. Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins. J Antimicrob Chemother 1992, 29 (Suppl A), 1-6   DOI
4 Isert D, Klesel N, Limbert M, Markus A, Seibert G, Schrinner E. Pharmacokinetics of cefpirome administered intravenously or intramuscularly to rats and dogs. J Antimicrob Chemother 1992, 29 (Suppl A), 31-37   DOI
5 Muller M, Rohde B, Kovar A, Georgopoulos A, Eichler HG, Derendorf H. Relationship between serum and free interstitial concentrations of cefodizime and cefpirome in muscle and subcutaneous adipose tissue of healthy volunteers measured by microdialysis. J Clin Pharmacol 1997, 37, 1108-1113   DOI   ScienceOn
6 Rule R, Quiroga GH, Rubio M, Buschiazzo HO, Buschiazzo PM. The pharmacokinetics of ceftazidime in lactating and non-lactating cows. Vet Res Commun 1996, 20, 543-550   DOI
7 Sauermann R, Delle-Karth G, Marsik C, Steiner I, Zeitlinger M, Mayer-Helm BX, Georgopoulos A, Muller M, Joukhadar C. Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients. Antimicrob Agents Chemother 2005, 49, 650-655   DOI   ScienceOn
8 Wisemann LR, Lamb HM. Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia. Drugs 1997, 54, 117-140   DOI   ScienceOn
9 Klesel N, Seeger K. Pharmacokinetic properties of the new cephalosporin antibiotic HR 810 in animals. Infection 1983, 11, 318-321
10 Jafari HS, Saez-Llorens X, Ramilo O, Shelton SL, McCracken GH Jr. Pharmacokinetics and antibacterial efficacy of cefpirome (HR 810) in experimental Escherichia coli and Haemophilus influenzae type b meningitis. Antimicrob Agents Chemother 1991, 35, 220-223   DOI   ScienceOn
11 Paradis D, Vallee F, Allard S, Bisson C, Daviau N, Drapeau C, Auger F, LeBel M. Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem and ciprofloxacin. Antimicrob Agents Chemother 1992, 36, 2085-2092   DOI   ScienceOn
12 Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed. pp. 433- 444, Marcel Dekker, New York, 1982
13 Kita Y, Yamaaki T, Imada A. Comparative pharmacokinetics of SCE-2787 and related antibiotics in experimental animals. Antimicrob Agents Chemother 1992, 36, 2481-2486   DOI   ScienceOn
14 Nakanomyo H, Esumi Y, Takaichi M, Seki H, Ninomiya S, Okamura Y, Sudo Y. Study on the pharmacokinetics of cefepime (II). Jap J Antibiot 1992, 45, 938-942
15 Bertram MA, Bruckner DA, Young LS. In vitro activity of HR 810, a new cephalosporin. Antimicrob Agents Chemother 1984, 26, 277-279   DOI   ScienceOn
16 Kavi J, Ashby JP, Wise R, Donovan IA. Intraperitoneal penetration of cefpirome. Eur J Clin Microbiol Infect Dis 1989, 8, 556-558   DOI
17 Sharma SK, Srivastava AK. Cefotaxime pharmacokinetics in male buffalo calves following multiple dosing. Vet Arh 2003, 73, 191-197
18 Mrestani Y, Bretschneider B, Hartl A, Neubert RHH. Invitro and in-vivo studies of cefpirom using bile salts as absorption enhancers. J Pharm Pharmacol 2003, 55, 1601- 1606   DOI   ScienceOn
19 Arai S, Kobayashi S, Hayashi S, Sakaguchi T. Distribution of cefpirome (HR 810) to exudate in the croton oil-induced rat granuloma pouch and its therapeutic effects on experimental infections in the pouch. Antimicrob Agents Chemother 1988, 32, 1396-1399   DOI   ScienceOn
20 Gardner SY, Papich MG. Comparison of cefepime pharmacokinetics in neonatal foals and adult dogs. J Vet Pharmacol Ther 2001, 24, 187-192   DOI   ScienceOn